Delivery Order SPE2DB25D3201-SPE2DB26FNNNB
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $59,501.28 to AmerisourceBergen Drug Corp for ENBREL 50 mg/ml SureClick auto-injector pens. This competitively awarded, firm fixed price delivery order was issued on October 22, 2025, with an ultimate completion date of October 23, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. ENBREL is a biologic immunosuppressant medication commonly used to treat rheumatoid arthritis, psoriasis, and...
- The Defense Logistics Agency awarded a $23,960.38 delivery order to AmerisourceBergen Drug Corp for ENBREL 50 MG/ML SureClick auto-injector pens, with an ultimate completion date of August 21, 2025. This non-competitive, firm fixed-price delivery order was issued on August 20, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $10,388.67 to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injector pens. This competitive, firm fixed-price delivery order was issued on August 25, 2025, with an ultimate completion date of August 26, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Enbrel is a biologic immunosuppressant medication used to treat rheumatoid arthritis and other autoimmune...
- The Defense Logistics Agency awarded a $41,652.21 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injector pens, with an ultimate completion date of September 29, 2025. This competitive award carries no set-aside designation and represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed and delivered from the contractor's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $33,637.70 to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injector pens on September 9, 2025, with a completion date of September 10, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Enbrel is a biologic immunosuppressant medication used to treat rheumatoid...
- The Defense Logistics Agency awarded a delivery order valued at $10,357.26 to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injector pens, with an ultimate completion date of August 20, 2025. This non-set-aside, firm fixed price delivery order was issued under a competitive procurement process and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. Enbrel is a biologic immunosuppressant medication commonly used to treat rheumatoid arthritis...
- The Defense Logistics Agency awarded a $34,953.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENBREL 50 MG/ML SureClick auto-injector pharmaceutical supply. The contract, executed on September 17, 2025, represents a non-competitive delivery order with an ultimate completion date of September 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's substantial...
- The Defense Logistics Agency awarded a delivery order valued at $15,467.93 to AmerisourceBergen Drug Corp for ENBREL 50 MG/ML SureClick auto-injector pens, with an ultimate completion date of June 25, 2025. This firm fixed price delivery order represents a non-set-aside competitive award and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award is issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for ENBREL 50 MG/ML SureClick auto-injectors valued at $9,253.56 on July 30, 2025, with a completion date of July 31, 2025. This firm fixed price, non-competitive delivery order represents pharmaceutical procurement for military healthcare needs and is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, the company's corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a $67,548.68 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors. The contract, which was competitively awarded with no set-aside designation, was executed on August 13, 2025, with an ultimate completion date of August 14, 2025. Performance will be conducted at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- SPE2DB25D3201Indefinite Delivery Contract
- SPE2DB25D3201-SPE2DB26FNNNBDelivery Order
The Defense Logistics Agency awarded a $30,345.64 delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/ml SureClick auto-injector pens, with an ultimate completion date of October 23, 2025. This is a firm fixed-price, non-set-aside award issued on October 22, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of medications and medical supplies to support military healthcare programs globally. ENBREL is a biologic immunosuppressant medication used to treat rheumatoid arthritis and other inflammatory conditions, and the SureClick delivery mechanism is a prefilled, single-use auto-injector system commonly utilized in military and federal healthcare settings for ease of administration and patient compliance. AmerisourceBergen, as a major pharmaceutical distributor and critical vendor for federal medical procurement, regularly fulfills competitive delivery orders through the DLA Medical Supply Chain for brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $30.3k | 10/22/25 |